Plored. We have demonstrated that IL-28B genetic variants would not
Plored. We have demonstrated that IL-28B genetic variants would not determine either early viral kinetics or final treatment outcome in HCV-2 treatment-experienced patients. On the other hand, better on-treatment responses…